Discover
SBRA
Sabra Health Care REIT, Inc.
19.74
2 x 14.41
1 x 19.82
bid
ask
-
0.41
2.03%
2 @ 07:30 PM
19.70 -0.04 (0.20%)
| Ytd | 4.22% | |
| 1y | 4.67% |
19.70
day range
20.07
17.23
52 week range
22.39
| Open | 20.07 | Prev Close | 20.15 | Low | 19.70 | High | 20.07 | Mkt Cap | 5.04B |
| Vol | 5.47M | Avg Vol | 2.81M | EPS | 0.26 | P/E | 75.92 | Forward P/E | 24.37 |
| Beta | 0.64 | Short Ratio | 8.22 | Inst. Own | 105.29% | Dividend | 1.20 | Div Yield | 5.96 |
| Ex Div Date | 08-14 | Earning | 11-04 | 50-d Avg | 20.71 | 200-d Avg | 19.92 | 1yr Est | 22.79 |
| Income Statement | |||
| Total Revenue | 235.87M | ||
| Revenues (USD) | 235.87M | ||
| Gross Profit | 235.87M | ||
| Operating Expenses | 267.92M | ||
| Selling, General and Administrative Expense | 16.82M | ||
| Operating Income | -32.05M | ||
| Interest Expense | 29.78M | ||
| Income Tax Expense | 678.00K | ||
| Net Income | -25.20M | ||
| Net Income Common Stock | -25.20M | ||
| Net Income Common Stock (USD) | -25.20M | ||
| Consolidated Income | -25.25M | ||
| Net Income to Non-Controlling Interests | -46.00K | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Dividends per Basic Common Share | 0.30 | ||
| Earning Before Interest & Taxes (EBIT) | 5.26M | ||
| Earning Before Interest & Taxes (USD) | 5.26M | ||
| Weighted Average Shares | 252.27M | ||
| Weighted Average Shares Diluted | 252.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 238.34M | ||
| Cash and Equivalents (USD) | 238.34M | ||
| Investments | 228.97M | ||
| Trade and Non-Trade Receivables | 130.10M | ||
| Property, Plant & Equipment Net | 4.83B | ||
| Total Assets | 5.51B | ||
| Total Debt | 2.63B | ||
| Total Liabilities | 2.76B | ||
| Accumulated Retained Earnings (Deficit) | -2.15B | ||
| Accumulated Other Comprehensive Income | 6.10M | ||
| Shareholders Equity | 2.75B | ||
| Shareholders Equity (USD) | 2.75B | ||
| Total Debt (USD) | 2.63B | ||
| Goodwill and Intangible Assets | 82.95M | ||
| Trade and Non-Trade Payables | 114.95M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 56.38M | ||
| Net Cash Flow from Financing | -57.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 114.96M | ||
| Capital Expenditure | -116.14M | ||
| Issuance (Purchase) of Equity Shares | 55.95M | ||
| Issuance (Repayment) of Debt Securities | -37.53M | ||
| Payment of Dividends & Other Cash Distributions | -75.66M | ||
| Net Cash Flow from Investing | 86.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 202.61M | ||
| Net Cash Flow from Operations | 85.82M | ||
| Effect of Exchange Rate Changes on Cash | -72.00K | ||
| Share Based Compensation | 4.09M | ||